- Release Date: 13/05/25 14:06
- Summary: NEU receives FDA minutes and re-confirms Phase 3 endpoints
- Price Sensitive: No
- Download Document 161.63KB
- Forums
- ASX - By Stock
- NEU
- Ann: NEU receives FDA minutes and re-confirms Phase 3 endpoints
NEU
neuren pharmaceuticals limited
Add to My Watchlist
1.23%
!
$17.66

Ann: NEU receives FDA minutes and re-confirms Phase 3 endpoints
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$17.66 |
Change
-0.220(1.23%) |
Mkt cap ! $2.240B |
Open | High | Low | Value | Volume |
$17.93 | $18.06 | $17.63 | $8.057M | 451.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 151 | $17.66 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$17.67 | 730 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 211 | 17.650 |
16 | 12326 | 17.640 |
8 | 794 | 17.630 |
7 | 1306 | 17.620 |
4 | 847 | 17.610 |
Price($) | Vol. | No. |
---|---|---|
17.660 | 575 | 9 |
17.670 | 1783 | 21 |
17.680 | 1400 | 12 |
17.690 | 825 | 12 |
17.700 | 2112 | 9 |
Last trade - 13.09pm 13/08/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |